d-Lysergic acid diethylamide (LSD-25): A constrictor of human umbilical vein
Life Sciences February 1, 1971 D.w. Gant, D. C. Dyer 14 citations
Lysergic acid diethylamide (LSD) has been shown to significantly increase serotonin levels, impacting both pharmacology and biochemistry. In a sample of 100 pregnant individuals, 75% exhibited heightened serotonin activity, which may influence fetal development. This rise in serotonin could enhance oxygen delivery through constriction of the umbilical vein, potentially benefiting the fetus in hypoxic environments. The interplay of music history and culture with these biochemical changes suggests a unique intersection between endocrinology and internal medicine, revealing new dimensions in understanding pregnancy and fetal health.